Top Medical Searches

FDA names drugmakers potentially acting to delay cheap generics

(Reuters) – The U.S. Food and Drug Administration on Thursday listed drugmakers, including Celgene Corp , Johnson & Johnson , Gilead Sciences and Novartis AG , who the regulator says are potentially blocking access to samples of their drugs to delay generic competition.

 Read more…

Be Sociable, Share!
May 17th, 2018 Posted in Drug
Copyright 2008 © Drugs and Diseases. Developed by Axilosoft
Home | About Us | Privacy Policy | Contact Us